ID   Y-MESO-14
AC   CVCL_5179
SY   Y-Meso-14
DR   cancercelllines; CVCL_5179
DR   Cosmic; 2759219
DR   GEO; GSM552527
DR   GEO; GSM850302
DR   Progenetix; CVCL_5179
DR   RCB; RCB5668
DR   Wikidata; Q54995139
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6515; LATS2; Zygosity=Homozygous (PubMed=21245096).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Lys116Glyfs*5 (c.349_359del11); Zygosity=Unspecified (PubMed=26011428).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000457921; Zygosity=Unspecified (PubMed=21245096).
CC   Omics: Array-based CGH.
CC   Omics: Transcriptome analysis by microarray.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
RX   PubMed=19380521; DOI=10.1093/carcin/bgp097;
RA   Kawaguchi K., Murakami H., Taniguchi T., Fujii M., Kawata S.,
RA   Fukui T., Kondo Y., Osada H., Usami N., Yokoi K., Ueda Y., Yatabe Y.,
RA   Ito M., Horio Y., Hida T., Sekido Y.;
RT   "Combined inhibition of MET and EGFR suppresses proliferation of
RT   malignant mesothelioma cells.";
RL   Carcinogenesis 30:1097-1105(2009).
//
RX   PubMed=21245096; DOI=10.1158/0008-5472.CAN-10-2164;
RA   Murakami H., Mizuno T., Taniguchi T., Fujii M., Ishiguro F., Fukui T.,
RA   Akatsuka S., Horio Y., Hida T., Kondo Y., Toyokuni S., Osada H.,
RA   Sekido Y.;
RT   "LATS2 is a tumor suppressor gene of malignant mesothelioma.";
RL   Cancer Res. 71:873-883(2011).
//
RX   PubMed=22286761; DOI=10.1038/onc.2012.5;
RA   Mizuno T., Murakami H., Fujii M., Ishiguro F., Tanaka I., Kondo Y.,
RA   Akatsuka S., Toyokuni S., Yokoi K., Osada H., Sekido Y.;
RT   "YAP induces malignant mesothelioma cell proliferation by upregulating
RT   transcription of cell cycle-promoting genes.";
RL   Oncogene 31:5117-5122(2012).
//
RX   PubMed=26011428; DOI=10.1111/cas.12698; PMCID=PMC4556387;
RA   Hakiri S., Osada H., Ishiguro F., Murakami H., Murakami-Tonami Y.,
RA   Yokoi K., Sekido Y.;
RT   "Functional differences between wild-type and mutant-type
RT   BRCA1-associated protein 1 tumor suppressor against malignant
RT   mesothelioma cells.";
RL   Cancer Sci. 106:990-999(2015).
//
RX   PubMed=28553954; DOI=10.1038/onc.2017.147;
RA   Kato T., Sato T., Yokoi K., Sekido Y.;
RT   "E-cadherin expression is correlated with focal adhesion kinase
RT   inhibitor resistance in merlin-negative malignant mesothelioma
RT   cells.";
RL   Oncogene 36:5522-5531(2017).
//